Suzanne Topalian

Dr. Suzanne Topalian, a leader in cancer immunotherapy, shares her journey from surgical residency to groundbreaking research at Johns Hopkins. She discusses the transformative impact of PD-1 inhibitors, demonstrating tumor regression in advanced cancers. Topalian highlights the importance of tumor-infiltrating lymphocytes and explores the potential of neoadjuvant immunotherapy. With insights on biomarker research, she emphasizes collaboration and mentorship in advancing cancer treatments, all while reflecting on her passions beyond science.